EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics Pharmaceuticals, as an Entrepreneur Of The Year® 2024 Pacific Southwest Award Winner

Core Insights - Scott Struthers, Ph.D., founder and CEO of Crinetics Pharmaceuticals, has been awarded the Entrepreneur Of The Year® 2024 Pacific Southwest Award, recognizing his leadership in high-growth companies [1][4]. Company Overview - Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company focused on discovering, developing, and commercializing novel therapeutics for endocrine diseases and endocrine-related tumors [3][16]. - The company was founded in 2008 and has grown to over 300 employees, emphasizing a collaborative approach to innovation in treatment [3]. - Crinetics is advancing its lead drug candidate, paltusotine, which is expected to submit a New Drug Application to the FDA by the end of 2024 [3][16]. - The company has a robust pipeline of internally discovered drug candidates targeting various endocrine conditions, including acromegaly and congenital adrenal hyperplasia [16]. Awards and Recognition - As a Pacific Southwest award winner, Dr. Struthers is eligible for the Entrepreneur Of The Year 2024 National Awards, with winners announced in November [4]. - The Entrepreneur Of The Year program has recognized over 11,000 entrepreneurs since its inception in 1986, expanding to nearly 80 countries [8].